The tech industry is experiencing a dramatic shakeup. Two of its giants, Nvidia and Intel, are heading in opposite directions. Nvidia, once a niche player in graphics processing, has become the world’s most valuable company, surpassing Apple and Microsoft in market capitalization. Meanwhile, Intel, a former titan of computing innovation, has seen its stock price plummet, its CEO retire and its place in the Dow Jones Industrial Average handed over to Nvidia.
At first glance, the rise and fall of these companies might seem irrelevant to healthcare. But the strategic decisions that propelled Nvidia to dominance—and sent Intel into decline—offer three critical lessons for an industry under increasing pressure.
With half the country unable to afford necessary medical care, patient satisfaction at a 20-year low, and government intensifying its efforts to slash healthcare spending, the industry has reached an inflection point. If healthcare professionals fail to adapt to these mounting pressures, they risk jeopardizing both their livelihoods and the well-being of those they serve.
Lesson One: Price Matters
Intel learned the hard way that even industry leaders offering exceptional quality can’t escalate prices indefinitely.
In the 1970s, Intel dominated the memory chip market, producing high-performance silicon semiconductors at premium prices. However, by the end of the decade, Japanese competitors began offering good-quality chips at far lower prices. Faced with declining market share and shrinking profits, Intel’s CEO Andy Grove and founder Gordon Moore made a pivotal decision in the early 1980s: they exited the memory chip market entirely and pivoted to microprocessors—uniquely designed chips that help our cars, refrigerators and phones run.
Despite internal resistance and financial challenges during the transition, Intel’s decision to pivot from memory chips to microprocessors not only saved the company but established its technological dominance for the next two decades. This bold move illustrates the necessity of strategic change in response to shifting market forces.
Healthcare professionals face a similarly urgent need to adapt. For years, physicians operating under the traditional fee-for-service model have sustained their incomes by performing more procedures and charging higher fees. But these strategies are no longer viable.
Medicare’s recent announcement of a 2.9% cut to physician reimbursement rates for 2025—and private insurers signaling potential parallel reductions—make it clear that the financial model of the past is crumbling. Healthcare professionals must adapt to survive. The question is: how?
Lesson Two: There’s More Than One Way To Create Value
Intel’s success in transitioning from memory chips to microprocessors wasn’t just about abandoning a failing product. It was about recognizing and capitalizing on an emerging opportunity.
In the 21st century, however, Intel’s resistance to change proved costly. While Intel remained focused on traditional CPUs (central processing units)—designed for sequential tasks like word processing and internet searches—Nvidia surged ahead by pioneering a newer, more powerful technology: graphics processing units or GPUs.
Initially created to render the complex visuals of video games, Nvidia’s GPUs contain hundreds of microprocessors capable of operating in parallel. This allows them to perform thousands of calculations simultaneously, making GPUs far more effective than CPUs for tasks requiring extensive data processing. This adaptability has made GPUs indispensable for generative AI applications, including natural language processing and large-scale data analysis. This strategic pivot propelled Nvidia to industry dominance and unmatched market success.
For businesses using Nvidia’s chips, the results outweigh the costs. Applications powered by GPUs allow a few individuals to accomplish work that would otherwise require a much larger team. The lesson for healthcare is clear: success lies in meeting the future needs of patients, not clinging to outdated approaches that worked in the past.
Historically, healthcare primarily served to meet the needs of patients with acute conditions like pneumonia, appendicitis or broken bones. The fee-for-service model was built for this, allowing providers to bill for each specific intervention. But today, the landscape has shifted dramatically. Chronic diseases like diabetes and hypertension now account for 60% of all medical conditions and at least 70% of healthcare costs.
Just as Nvidia reimagined its offerings to meet the demands of the future, healthcare professionals must shift their focus and technology to address the challenges of chronic disease. By preventing these conditions and managing them more effectively when they occur, doctors could reduce complications such as heart attacks, strokes, cancer and kidney failure by 30-50%, according to CDC estimates. This would not only save lives and improve public health but also save hundreds of billions of dollars annually for employers and government healthcare programs.
From a strategic perspective, this shift would parallel Nvidia’s success with GPUs (in contrast to Intel’s failure to adapt beyond CPUs). For healthcare professionals, adopting a similar approach could lead to increased income and greater autonomy.
Today, chronic diseases remain poorly managed. Hypertension, responsible for 40% of strokes, is controlled in only 60% of patients. Diabetes, the leading cause of heart attacks and kidney failure, is effectively managed less than half the time. Addressing these gaps would not only improve outcomes but also empower clinicians to reclaim control of medical care—leading to the third and final lesson.
Lesson Three: Success Requires Risk
Back when Intel’s leaders were grappling with a faltering memory chip business, Andy Grove famously asked Gordon Moore, “If we got kicked out and the board brought in a new CEO, what do you think he would do?”
Both agreed: the new leader would exit memory chips. That decision required bold commitment and a greater tolerance for risk—something most healthcare leaders lack.
Nearly two decades ago, Intel hesitated to pivot to GPUs, clinging to CPUs as its core business. Had Intel leveraged its immense resources to embrace GPUs, it would have crushed Nvidia. By failing to act, the company endured financial setbacks and has become increasingly irrelevant.
Healthcare professionals must choose whether they want to be Nvidia or Intel— embracing a new strategy that benefits providers, payors and patients, or opting to stick to outdated practices and payment models.
Thousands of clinicians have already tried to escape medicine’s mounting challenges—financial strain, burnout, declining reimbursement—by joining forces with hospitals or selling their practices to private equity firms. But based on my conversations with hundreds of doctors, most describe the results as disappointing. Many report a loss of autonomy and unfulfilled promises of financial gain, while burnout rates remain as high as ever.
To improve their fortunes, healthcare professionals must shift to a model of care designed to address chronic disease. Instead of managing patients through sporadic office visits every few months, healthcare professionals must adopt a more continuous approach. Wearable devices can provide daily monitoring, while generative AI tools can notify patients when their conditions are stable or require intervention.
Achieving success will also demand that they form large physician groups, prioritize primary care and empower patients with modern technology.
This shift in care delivery will require a new payment model. Fee-for-service reimbursement, which incentivizes volume over outcomes, is misaligned with the goal of preventing life-threatening medical complications. Instead, clinicians must adopt value-based care, where providers receive a set fee to manage the health of a population. This model rewards doctors for preventing and better managing chronic diseases, aligning financial incentives with patient health outcomes.
The transformation won’t be easy or painless. Some hospitals will close and traditional practices will shrink. Residency programs will need to train more primary care physicians and fewer specialists. But these changes are essential to the survival of the profession. Failure to adapt will only deepen the challenges facing both patients and clinicians in the years ahead.
The Biggest Lesson: Act Now
The rise of Nvidia and the fall of Intel underscore a universal truth: change happens slowly—until it doesn’t. Healthcare has reached a tipping point, and clinicians who embrace innovation with courage will thrive, while those who hesitate or take only small steps forward will languish.
Andy Grove captured this reality when he said, “Most companies don’t die because they are wrong; most die because they don’t commit themselves. They fritter away their valuable resources while attempting to make a decision. The greatest danger is in standing still.”
Healthcare professionals must now decide whether they will lead the way like Nvidia or face irrelevance like Intel. The stakes couldn’t be higher.
